Viewing Study NCT01678404


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2026-03-09 @ 4:09 AM
Study NCT ID: NCT01678404
Status: UNKNOWN
Last Update Posted: 2012-09-05
First Post: 2012-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma
Sponsor: Korea Cancer Center Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module